The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells
Open accessAbstract
The efficacy of cisplatin in cancer chemotherapy is limited by the development of resistance. Although the molecular mechanisms involved in chemoresistance are poorly understood, cellular response to cisplatin is known to involve activation of MAPK and other signal transduction pathways. An understanding of early signal transduction events in the response to cisplatin could be valuable for improving the efficacy of cancer therapy. We compared cisplatin-induced activation of three MAPKs, JNK, p38, and ERK, in a cisplatin-sensitive human ovarian carcinoma cell line (2008) and its resistant subclone (2008C13). The JNK and p38 pathways were activated differentially in response to cisplatin, with the cisplatin-sensitive cells showing prolonged activation (8-12 h) and the cisplatin-resistant cells showing only transient activation (1-3 h) of JNK and p38. In the sensitive cells, inhibition of cisplatin-induced JNK and p38 activation blocked cisplatin-induced apoptosis; persistent activation of JNK resulted in hyperphosphorylation of the c-Jun transcription factor, which in turn stimulated the transcription of an immediate downstream target, the death inducer Fas ligand (FasL). Sequestration of FasL by incubation with a neutralizing anti-FasL antibody inhibited cisplatin-induced apoptosis. In contrast, chemoresistance in 2008C13 cells was associated with failure to up-regulate FasL. Moreover, in these cells, selective stimulation of the JNK/p38 MAPK pathways by adenovirus-mediated delivery of recombinant MKK7 or MKK3 led to sensitization to apoptosis through reactivating FasL expression. Thus, the JNK > c-Jun > FasL > Fas pathway plays an important role in mediating cisplatin-induced apoptosis in ovarian cancer cells, and the duration of JNK activation is critical in determining whether cells survive or undergo apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,287
Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Zou, H., Henzel, W. J., Liu, X., Lutschg, A., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80501-2 · Cited by 3,145
Hibi, M., Lin, A., Smeal, T., Minden, A., & Karin, M. (1993) · Genes & Development · doi:10.1101/gad.7.11.2135 · Cited by 1,886
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
Verheij, M., Bose, R., Hua Lin, X., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., et al. (1996) · Nature · doi:10.1038/380075a0 · Cited by 1,767
Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., Jones, S. N., Flavell, R. A., & Davis, R. J. (2000) · Science · doi:10.1126/science.288.5467.870 · Cited by 1,728
A Matter of Life and Cell Death
Evan, G., & Littlewood, T. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,523
Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug
(1999) · Wiley eBooks · doi:10.1002/9783906390420 · Cited by 1,296
Regulation of transcription by MAP kinase cascades
Treisman, R. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80067-6 · Cited by 1,296
Raingeaud, J., Whitmarsh, A. J., Barrett, T., Dérijard, B., & Davis, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1247 · Cited by 1,278
Bossy‐Wetzel, E., Newmeyer, D. D., & Green, D. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.37 · Cited by 1,225
Autoactivation of Procaspase-9 by Apaf-1-Mediated Oligomerization
Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., & Alnemri, E. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80095-7 · Cited by 1,119
Regulation of JNK signaling by GSTp
Adler, V. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1321 · Cited by 1,116
Friesen, C., Herr, I., Krammer, P. H., & Debatin, K.-M. (1996) · Nature Medicine · doi:10.1038/nm0596-574 · Cited by 974
Cobb, M. H. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00056-x · Cited by 875
Dual specificity phosphatases: a gene family for control of MAP kinase function
CAMPS, M., NICHOLS, A., & ARKINSTALL, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.6 · Cited by 811
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
Keyse, S. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00075-7 · Cited by 807
Cellular stress response and apoptosis in cancer therapy
Herr, I., & Debatin, K.-M. (2001) · Blood · doi:10.1182/blood.v98.9.2603 · Cited by 800
A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death
Ham, J., Babij, C., Whitfield, J., Pfarr, C. M., Lallemand, D., Yaniv, M., & Rubin, L. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90331-3 · Cited by 796
Protein tyrosine phosphatases in signal transduction
Neel, B. G., & Tonks, N. K. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80063-4 · Cited by 753
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., & Green, D. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80054-4 · Cited by 721
Behrens, A., Sibilia, M., & Wagner, E. F. (1999) · Nature Genetics · doi:10.1038/6854 · Cited by 676
Cisplatin: From DNA damage to cancer chemotherapy
Cohen, S. M., & Lippard, S. J. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)67026-0 · Cited by 615
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H., & Lazo, J. S. (1988) · Science · doi:10.1126/science.3175622 · Cited by 601
Whitfield, J., Neame, S. J., Paquet, L., Bernard, O., & Ham, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00239-2 · Cited by 565
c-Jun is essential for normal mouse development and hepatogenesis
Hilberg, F., Aguzzi, A., Howells, N., & Wagner, E. F. (1993) · Nature · doi:10.1038/365179a0 · Cited by 539
Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents
Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., & Kufe, D. W. (1995) · Nature · doi:10.1038/376785a0 · Cited by 485
Le-Niculescu, H., Bonfoco, E., Kasuya, Y., Claret, F.-X., Green, D. R., & Karin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.751 · Cited by 465
Self-citationRole of p38 and JNK Mitogen-Activated Protein Kinases in the Activation of Ternary Complex Factors
Whitmarsh, A. J., Yang, S.-H., Su, M. S.-S., Sharrocks, A. D., & Davis, R. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2360 · Cited by 455
Zanke, B. W., Boudreau, K., Rubie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F.-F., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00547-x · Cited by 444
Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH 2 -terminal kinase
Tournier, C., Whitmarsh, A. J., Cavanagh, J., Barrett, T., & Davis, R. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7337 · Cited by 379
Mechanisms of apoptosis avoidance in cancer
Reed, J. C. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199901000-00014 · Cited by 374
Watson, A., Eilers, A., Lallemand, D., Kyriakis, J., Rubin, L. L., & Ham, J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00751.1998 · Cited by 360
Three distinct signalling responses by murine fibroblasts to genotoxic stress
Liu, Z.-G., Baskaran, R., Lea-Chou, E. T., Wood, L. D., Chen, Y., Karin, M., & Wang, J. Y. J. (1996) · Nature · doi:10.1038/384273a0 · Cited by 355
Mann, S. C., Andrews, P. A., & Howell, S. B. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684878 · Cited by 349
Wang, Y., Su, B., Sah, V. P., Brown, J. H., Han, J., & Chien, K. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5423 · Cited by 339
Self-citationHerdegen, T., Claret, F.-X., Kallunki, T., Martin-Villalba, A., Winter, C., Hunter, T., & Karin, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05124.1998 · Cited by 330
Self-citationBenhar, M., Dalyot, I., Engelberg, D., & Levitzki, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6913-6926.2001 · Cited by 306
Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F., & Karin, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00193-8 · Cited by 295
Involvement of the MKK6-p38γ Cascade in γ-Radiation-Induced Cell Cycle Arrest
Wang, X., McGowan, C. H., Zhao, M., He, L., Downey, J. S., Fearns, C., Wang, Y., Huang, S., & Han, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4543-4552.2000 · Cited by 249
Self-citationCisplatin induces a persistent activation of JNK that is related to cell death
Sánchez-Perez, I., Murguía, J. R., & Perona, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201578 · Cited by 236
Faris, M., Kokot, N., Latinis, K., Kasibhatla, S., Green, D. R., Koretzky, G. A., & Nel, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.134 · Cited by 233
Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., & Mercola, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14041 · Cited by 229
Osborn, M. T., & Chambers, T. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30950 · Cited by 207
Faris, M., Latinis, K. M., Kempiak, S. J., Koretzky, G. A., & Nel, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5414 · Cited by 190
Holmstrom, T. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5418 · Cited by 186
Kolbus, A., Herr, I., Schreiber, M., Debatin, K.-M., Wagner, E. F., & Angel, P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.575-582.2000 · Cited by 158
Activation of p38 Mitogen-activated Protein Kinase by c-Abl-dependent and -independent Mechanisms
Pandey, P., Raingeaud, J., Kaneki, M., Weichselbaum, R. R., Davis, R. J., Kufe, D. W., & Kharbanda, S. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23775 · Cited by 142
CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin
Sánchez‐Pérez, I., Martínez-Gomáriz, M., Williams, D. J., Keyse, S. M., & Perona, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203887 · Cited by 142
Eichhorst, S. T., Müller, M., Li‐Weber, M., Schulze‐Bergkamen, H., Angel, P. E., & Krammer, P. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7826-7837.2000 · Cited by 139
Fulda, S., Strauß, G., Meyer, É., & Debatin, K. (2000) · Blood · doi:10.1182/blood.v95.1.301 · Cited by 127
Identification of Genes That Mediate Sensitivity to Cisplatin
Niedner, H., Christen, R. D., Lin, X., Kondo, A., & Howell, S. B. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1153 · Cited by 126
Wu, Z., Wu, J., Jacinto, E., & Karin, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7407 · Cited by 124
Cooperation between Syk and Rac1 Leads to Synergistic JNK Activation in T Lymphocytes
Jacinto, E., Werlen, G., & Karin, M. (1998) · Immunity · doi:10.1016/s1074-7613(00)80456-2 · Cited by 121
Stadheim, T. A., & Kucera, G. L. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00099-6 · Cited by 106
Lack of c‐Jun activity increases survival to cisplatin
Sánchez‐Pérez, I., & Perona, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00690-0 · Cited by 95
Eichhorst, S. T., Müerköster, S. S., Weigand, M. A., & Krammer, P. H. (2001) · PubMed · Cited by 79
Li, J., Delmastro, D. A., Vaisman, A., Solle, M., & Chaney, S. G. (1996) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050568 · Cited by 74
Yoshida, M., Khokhar, A. R., & Siddik, Z. H. (1994) · PubMed · Cited by 26
Self-citation
Cited by
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
DNA damage-induced cell death by apoptosis
Roos, W. P., & Kaina, B. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.007 · Cited by 1,500
Sui, X., Kong, N., Ye, L., Han, W., Zhou, J., Zhang, Q., He, C., & Pan, H. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.019 · Cited by 958
Self-citationSystems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
“as p38) and c-Jun N-terminal kinase 1 (JNK1).(171,172) Along similar lines, post-target CDDP resistance appears to be significantly influenced by the expression levels and”
Background
Metadata
- Authors
- Mansouri, A., Ridgway, L. D., Korapati, A. L., Zhang, Q., Tian, L., Wang, Y., Siddik, Z. H., Mills, G. B., & Claret, F. X.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 21
- Pages
- 19245-19256
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2023964913
- Cited by
- 377
- References
- 62
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.